“The growth, because the competition on the market give and became came under the expectations for the whole class,” clears up of Patrick Holmes, a Pfizer marketing vice president for drug, including Viagra. [See: "The inquiry lags and his competitor for Viagra."]
This is in spite of huge sums for DTC (direct-to-consumer spent) the advertisement for these drugs. Cialis and Levitra are given # 2 and # 4 in the form of dollars on DTC in the first and second quarter in 2004. According to TNS Media Intelligence / CMR, it was followed Cialis advertising expenses $ 137,000,000 for the first 10 months of 2004 of 133 million U.S. dollars for Levitra, and Viagra for $ 88,000,000. (Viagra was much lower, maybe because of the criticism of the FDA indications Viagra – namely through omission of information risks. DDMAC lake writing to Pfizer.]
Pharmaceutical marketing prognoses on course!
In February, 2004 organized a pharmaceutical marketing news survey with the title “Cialis / Levitra / Viagra: Which campaign has the biggest Staying Power?” where we asked, experts, around the share of the market for Viagra, Cialis, Levitra and investigate in six months. The predictions – on the left side – have explained quite as exact. According to the WSJ article, Viagra had 65% of the portion cited in Oct / Nov in 2004, while Cialis and Levitra divide 21% had a portion of 13% had. From all estimates Levitra should be able to make better.
Lacking DTC beyond the United States of the male factors?
A Glaxo speaker in London states, that to sell it hard to drugs without the help of the consumer’s advertisement. This may be true. In the USA where DTC is permitted has some data seem short flickering in the new regulations after 2004 AD for Cialis written Superbowl point (see “The New Prescription Written: mobilization of technology on the measurement of the change of the Physician behavior, how she appears”). Nevertheless, it it is difficult to distinguish Doctorates DTC of other kinds of publicity campaigns – like details to the doctor – and with firmness say that in every projection Rx writing is on the indication, instead of something else.
Maybe so many men a problem, because pharmaceutical company having to us believe Do Not want to pose?
I remember a conference in which a presentation of the Cialis marketing director hit so many like 1 in 2 men more than 40 in the USA from a certain measure against erection disorders will suffer. I looked the man to the man and my rights to my lefts and said: “one of these types is not able to do them on!”
Pfizer has in his FAQ on ED, says: “More than 30 million men in the United States suffer from a certain ED, under it possibly half of all men at the age of from 40 years to 70th”
The WSJ article dutifully repeats this appraisal: “The number of men the U.S. problems with some estimates to reach or maintain erections to put 30 millions.” Where they come from with this number? Now, they do not say, it could be Pfizer? Or maybe some independent experts? In the next sentence the authors cite journal Andrew R. McCullough, a urologist at New York University Medical center. The suture of an expert with the data itself lets a connection between the both. Is this plausible expert?
So remember that Dr. McCullough, according to Target Health, Inc. where he is basically became adviser “(sic) to examiner in numerous clinical studies of the erectile dysfunction, including the relevant studies for licensing of sildenafil. Currently he is ED studies with Bavarian Direct, TAP, Liliy-ICOS and Pfizer … and has a high degree adviser and expert for many enterprises, under it, Pfizer, Bavarian, Bristol Meyers Squibb, Vivus, Schering-Plough, Smith Kline Beecham, TAP and has served. ”
According to the Nationwide institute of diabetes and digestive and kidney illnesses, Nationwide of institute of Health, incidence [of the ED] rises with the old person: About 5 percent of the 40-year-old men and between 15 and 25 percent of The 65-year-old men experience ED. ”
TIP: Some interesting data about those of Pfizer Viagra I was made in an article published after this WSJ post (see above “Medicare plan the cover Viagra,” WSJ, 3/2/2005). After these data, the majority of the Viagra (61%) have been written for men less than 60 years: “There was approved by the FDA in 1998, about 16 million men have tried Viagra to Pfizer. Whole score, according to a speaker of Pfizer, men at the age of 69 from 60 to about 22% of the prescriptions are canceled for the medicine, during that more than 70 years are canceled about 17%. ”
I think, the marketer own drinking Kool Aid. They have overestimated the market and have tried, too many men in the category ED one. Many men can not hold on inconsistent ability, or inclination to an erection erections only briefly to reach, but she would like to say, they are “impotent” what implies what is ED. The indications, of course, rock, in which the problem by “ED” as fast as possible not to draw the attention. Therefore, DTC is TV the whole work is not able. It needs more education. See yesterday’s comments (“The DTC of like us know it”) for more about that!
See also: Men’s Herbs
